Navigation Links
InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
Date:1/5/2012

patients treated with Esbriet in CAPACITY, and both were directionally higher than in patients receiving placebo in CAPACITY.

With these new analyses, this is the third InterMune study to show similar changes in lung function following slightly more than one year of Esbriet therapy. A fourth study from Japan demonstrated that pirfenidone reduces decline in lung function at one year.   

Additional details of the RECAP analyses will be presented on the conference call and webcast InterMune will host at 8:30 a.m. EST this morning.

Phase 3 ASCEND Study

InterMune today reported that patient enrollment in the Phase 3 pirfenidone study, ASCEND, in the United States and certain additional territories is expected to be fully enrolled in the second quarter of 2012.

  • ASCEND is a double-blind, placebo-controlled trial of 52 weeks duration with a primary endpoint of change in FVC between baseline and Week 52.  The trial will enroll approximately 500 IPF patients with mild-to-moderate impairment in lung function.
  • InterMune expects that results from the study will be available in mid-2013. 

 

Guidance for 2011 Expenses

The company updated its financial guidance for operating expenses in 2011:

  • R&D expense: anticipated to be in a range of approximately $75 to $80 million, previously estimated during InterMune's Third Quarter 2011 earnings call to be in the range of $85 to $95 million.
  • SG&A expense: anticipated to be in a range of approximately $85 to $90 million, previously projected during InterMune's Third Quarter 2011 earnings call to be in the range of $75 to $85 million. 
  • Total Operating Expenses (R&D and SG&A): anticipated to be in a range of approximately $160 to $170 million, compared to the previously projecte
    '/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. InterMune Appoints Angus C. Russell to Board of Directors
2. InterMune to Release Third Quarter Financial Results on November 3
3. InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
4. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
5. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
6. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
7. InterMune to Present at J.P. Morgan Healthcare Conference
8. InterMune Reports Third Quarter 2010 Financial Results
9. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
10. InterMune to Release Second Quarter Financial Results on July 27
11. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... WEST ORANGE , N.J. and NEW BRUNSWICK, N.J., Sept. ... formal affiliation agreement that allows Kessler Foundation and ... to advance biomedical research, education and patient care ... , president and chief executive officer of Kessler ... of New Jersey Health Foundation. "The ...
(Date:9/30/2014)... , Sept. 30, 2014 The Eastern European ... established medical-device providers as well as new medical-device manufacturers ... while simultaneously looking at ways to reduce the cost ... distributors is one of the effective means to achieve ... distribution market in Eastern European and provides profiles of ...
(Date:9/30/2014)... Ariz. , Sept. 30, 2014 Passport ... North America , has launched FluFree.com, a website ... flu vaccinations. For 20 years, Passport Health ... including the flu. The launch of FluFree.com is designed ... vaccination and the number of people who actually chose ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 2Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 3
... 26 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Pharmaceuticals, Inc. (Huxley), which has rights to a ... the rare autoimmune disease Lambert Eaton Myasthenic Syndrome ... Products for Human Use of the European Medicines ...
... PINNACLE Network (TM) Links Thousands of Clinical ... Excellence , WASHINGTON, Oct. 26 The ... of the PINNACLE Network(TM), the first-ever registry-based cardiovascular ... each other and to the ACC,s National Cardiovascular ...
Cached Medicine Technology:BioMarin Acquires Huxley Pharmaceuticals, Inc. 2BioMarin Acquires Huxley Pharmaceuticals, Inc. 3BioMarin Acquires Huxley Pharmaceuticals, Inc. 4BioMarin Acquires Huxley Pharmaceuticals, Inc. 5BioMarin Acquires Huxley Pharmaceuticals, Inc. 6American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 2American College of Cardiology Launches the Nation's First Registry-Based Cardiovascular Practice Network 3
(Date:9/30/2014)... of Maryland-led research team has been awarded a ... of Health (NIH) to develop new imaging technologies ... understanding of how large networks of neurons in ... knowledge will help researchers identify the precise interactions ... like decision-making and speaking, and alterations in these ...
(Date:9/30/2014)... 2014 EverStryke , the permanent match ... SurvivalLife.com along with a free book and class all about ... Michaels, prompting an investigative review. , “Joe Marshall of ... survival and preparation niche, and this product is an excellent ... and survival products that Joe offers on his website to ...
(Date:9/30/2014)... 30, 2014 Elevate , the latest ... better in and out of the gym by providing natural ... the attention of Shane Michaels, prompting an investigative review. ... the reason most people simply just don’t have the ability ... focused at work, getting the motivation to finish a project, ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 ... providers in Turkey has gone up more than 79 ... The medical tourism company also reported total revenue tripled ... 2012. , The company’s professional strategy has allowed them ... — ultimately designed for patient comfort and privacy — ...
(Date:9/30/2014)... 30, 2014 Hospice & Palliative ... “In Celebration” gala, honoring three outstanding individuals for ... striving to provide extraordinary and dignified comfort, care ... serious or life-limiting illness. , The event was ... NY and recognized William (Bill) J. McGuinness, Director ...
Breaking Medicine News(10 mins):Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2
... New York, NY, August 6, 2009 Comprehensive health reform ... 13 million uninsured young adults ages 19-29 gain coverage, ... who now have coverage would not lose it, according ... coverage to all Americans through expansions in Medicaid and ...
... on medical tourism, exotic destinations , SATURDAY, Aug. 15 ... the U.S. government has a guidebook that could save ... and Prevention has released a new edition of ... as "The Yellow Book" for its distinctive cover, which ...
... , NEW YORK, Aug. 14 Healthcare may be on ... the price you pay at the pharmacy is actually getting the medicine ... to this report from Forest Laboratories at: http://inr.mediaseed.tv/oneClip _ ... Registered journalists can access video, audio, text, graphics and photos for ...
... , , , , ... Board: SNKTY), a Life Sciences company engaged in the research, development ... today announced revenues for its fiscal second quarter ended June 30, ... 31, 2009 and $691,000 reported in the comparable prior year period ...
... impact on cognition, study finds , FRIDAY, Aug. 14 ... difference in mental decline after the age of 70, ... the Aug. 1 issue of the American Journal ... background have an impact on cognitive functioning among the ...
... , Additional 28 New ... WASHINGTON, Aug. 14 Today, Secretary of Veterans Affairs Eric K. ... assistance in 28 additional communities across the country where the Department ... , , "VA is committed to providing high-quality ...
Cached Medicine News:Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 2Health News:Health reform proposals could help 13 million uninsured young adults gain coverage 3Health News:International Travel Health Guidebook Gets Updated 2Health News:Senetek PLC Reports Second Quarter 2009 Financial Results 2Health News:Senetek PLC Reports Second Quarter 2009 Financial Results 3Health News:Senetek PLC Reports Second Quarter 2009 Financial Results 4Health News:Senetek PLC Reports Second Quarter 2009 Financial Results 5Health News:Senetek PLC Reports Second Quarter 2009 Financial Results 6Health News:Rich, Poor See Similar Declines in Old Age 2Health News:Secretary Shinseki Announces Expansion of Counseling for Combat Veterans 2
Designed to fit a variety of 250 L and 300 ul multi-channel pipettors, this tip offers a secure fit and extra space for repeat pipetting....
... Finntip Filters are ideal for ... or for any work where ... are designed for pipetting DNA/RNA ... and other. For applications requiring ...
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
... Resistant Tips offer a safe alternative to ... designed for applications such as PCR(a), pipetting ... ART Tips are excellent for tissue culture, ... ART Tips prevent aerosol contaminants and liquids ...
Medicine Products: